Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check8 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has updated the contact details section for the study, replacing the previous information with new details about who to contact and where the study is taking place, along with a revision update from v2.12.2 to v2.13.2.SummaryDifference3%
- Check51 days agoChange DetectedRecent updates include new entries for November 2024, while previous updates from July 2024 have been removed.SummaryDifference0.6%
- Check58 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.